Recent

% | $
Quotes you view appear here for quick access.

Muscle Pharm Corp. Message Board

  • investig8girl investig8girl Jul 13, 2012 5:23 PM Flag

    REVISED FINANCIALS FOR 2011

    The revised financials are out.
    They show that MSLP spends $3, up from $2, for each $1 of Sales.
    They hemorrhage cash with every sale.
    They will be asking you DUPES for more money.
    This is one of the biggest P&D SCAMS committed so far.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • As reflected in the accompanying unaudited interim consolidated financial statements, the Company had a net loss of $12,448,545 and net cash used in operations of $2,645,448 for the six months ended June 30, 2011, and a working capital deficit and stockholders' deficit of $7,037,918 and $5,561,132, respectively, at June 30, 2011. These factors raise substantial doubt about the Company's ability to continue as a going concern.

      Other expenses for the six months ended June 30, 2011, were $9,467,552, as compared to $674,343 for the comparable six months ended June 30, 2010. The increase in other expenses of $8,793,209 is primarily attributable to the financing transactions the Company entered into during the six months ended June 30, 2011. The Company issued $3,753,733 in convertible notes during the six months ended June 30, 2011. These notes bore interest at rates ranging from 6% to 12% per annum. Interest expense during the six months ended June 30, 2011, increased $2,828,047 as compared to the comparable six months ended June 30, 2010. In addition, the convertible notes contained embedded derivatives, due to the Company not being able to determine the number of shares needed to settle the conversion privilege. As a result, on the commitment date of each financing, the Company recorded an aggregate derivative expenses of $4,057,859 and on the date of remeasurement, which is June 30, 2011, a change in fair market value of $634,770. There were no derivative liabilities recorded as of June 30, 2010.

      The Company also issued shares of the Company's common stock to satisfy aged accounts payable, accrued expenses and debt. The Company recorded a loss on settlement in the amount of $2,542,073 as a result of these transactions.

 
MSLP
4.35-0.18(-3.97%)Apr 27 3:52 PMEDT